Business Wire

GUANGZHOU-INFORMATION

18.11.2023 13:07:35 CET | Business Wire | Press release

Share
China’s Guangzhou Launches Conversations Between China and Italy to Showcase the Cooperation Achievements

China’s Guangzhou launched a special conversation on November 16 in Italy’s Rome, at which more than a dozen guests from both countries told their stories about cultural and economic cooperation, showcased the fruitful achievements between two sides.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20231118396482/en/

To view this piece of content from mms.businesswire.com, please give your consent at the top of this page.

China’s Guangzhou launches conversations between China and Italy to showcase the cooperation achievements. (Graphic: Business Wire)

Guangzhou, a metropolis in southern China, has been a trade gateway of China to the world for more than two thousand years.

According to Sun Yong, publicity director of Nansha District of Guangzhou, “At that time, Guangzhou received merchant ships from all over the world including Italy, when marked the prosperity of Maritime Silk Road.”

“Today, the world's largest luxury ro-ro passenger ship MOBY, operating in the Italian Mediterranean, was actually built by Guangzhou Shipyard International based in Nansha,” Sun continued, “we are still connected.”

Michele De Gasperis, President of the Italian One Belt One Road Institute, said that Guangzhou is not only a beautiful city, but also a city full of business opportunities.

“Recently I visited the Canton Fair held in Guangzhou and was deeply impressed. I firmly believe that Guangzhou will become an important trade and tourism destination in Italy,” said Gasperis.

During the event, the Italian pianist Giuseppe Ganzerli, performed with PEARL River piano. “I started to import Pearl River piano from Guangzhou for more than ten years. Pearl River is a beautiful river across Guangzhou city. I always tell my Italian clients that this piano is so beautiful just like the Pearl River itself,” said Gennaro Schlitzer, board member of Queen’s SRL.

Several chefs from Guangzhou Restaurants Group demonstrated Guangzhou cuisine at the event.

“Canton is famous for its unique cuisine, which has reached every corner of the world. But our relationship goes far beyond cooking,” Angelo Tabaro, former minister for culture of the Veneto Region said.

“Italy and China are the two nations with the longest-lived and richest cultural heritages.” He added, “From painting to music, literature to architecture, both countries have influenced the world in unique ways. Italian and Chinese companies collaborate in sectors ranging from automobiles to fashion, from technology to renewable energy.”

Edouard Suzeau, a young designer from Guangzhou Automobile Group (GAC) Design Studio Milan, said that “Milan was chosen as the location for our studio because the city’s ubiquitous car culture is a perfect fit with GAC’s mission and passion for automotive design.”

A modern sculpture called Embrace the World made by Guangzhou artist Zeng Zhenwei, was given to Laura Gallon, President of the Italian Arte Laguna Prize. “I believe that the art and culture exchange between our two nations can be carried forward,” Gallon said.

Statistic shows that in 2022, the bilateral trade volume between China and Italy reached US$77.9 billion, hit a record high.

“More exchanges in all sectors are expected,” Li Ran from China southern airlines said, “For example, we currently operate four round-trip flights per week between Guangzhou and Rome, and will increase to six per week in December this year.”

To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.

View source version on businesswire.com: https://www.businesswire.com/news/home/20231118396482/en/

About Business Wire

Business Wire
Business Wire
101 California Street, 20th Floor
CA 94111 San Francisco

http://businesswire.com
DK

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

FPT Named an OpenAI Select Partner6.8.2026 02:00:00 CEST | Press release

Global IT corporation FPT today announced that it has been named an OpenAI Select Partner within the OpenAI Partner Network. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260805503787/en/ FPT Named an OpenAI Select Partner The OpenAI Partner Network is a global program for partners to build, sell, and deliver AI solutions with OpenAI. It brings together partners with deep industry expertise, delivery capabilities, and customer relationships while equipping them with resources, enablement, and support to help enterprises adopt OpenAI frontier models and products and turn them into measurable impact. As an OpenAI Select Partner, FPT will continue working with OpenAI to help organizations build, deploy, and scale AI solutions responsibly and effectively. This work will help organizations get more useful work from every token and stronger performance per dollar with GPT‑5.6, while using ChatGPT Work to turn ambitious goals into

U.S. FDA Approves Takeda’s ORZEYFUL™ (oveporexton), the First and Only Medicine to Treat the Underlying Cause of Narcolepsy Type 16.8.2026 00:10:00 CEST | Press release

Adults Taking ORZEYFUL Experienced Significant and Meaningful Improvements Across the Full Range of Symptoms of Narcolepsy Type 1 (NT1) in Clinical Trials Compared to Those on Placebo As a First-in-Class Orexin Treatment, ORZEYFUL has the Potential to Redefine NT1 Care Beyond Individual Symptoms Takeda is Advancing U.S. Launch Preparations and Expects to Make ORZEYFUL Available Following Completion of the Drug Enforcement Administration (DEA) Scheduling Process Takeda (TSE:4502/NYSE:TAK) announced that the U.S. Food and Drug Administration (FDA) approved ORZEYFUL™ (oveporexton), an oral orexin receptor 2 (OX2R) agonist, for the treatment of narcolepsy type 1 (NT1, narcolepsy with cataplexy) in adults.* The persistent 24-hour nature of NT1 is driven by orexin deficiency and can severely impact people’s lives. As a first-in-class orexin treatment, ORZEYFUL is the only medicine indicated in the U.S. to treat the disease holistically rather than individual symptoms. “The FDA approval of OR

Compass Pathways Announces New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)5.8.2026 22:30:00 CEST | Press release

Compass Pathways plc (Nasdaq: CMPS), a biotechnology company dedicated to unlocking urgently needed new treatment options in mental health care, announced today that Compass granted equity awards under the Compass Pathways plc 2026 Inducement Plan to fourteen newly hired non-executive employees. The equity awards were granted on August 3, 2026 and consisted of options to purchase an aggregate of 139,355 shares and restricted share units or, in the case of employees in the United Kingdom nominal cost options, covering an aggregate of 66,300 shares. The options have an exercise price per share equal to $11.25, the closing price of the Company’s American Depositary Shares on the Nasdaq Global Select Market on the grant date, and will vest over a four-year period with 25% vesting on the first anniversary of the date of the grant and the remaining 75% vesting in equal monthly installments over the three-year period thereafter, subject to each employee’s continued employment. The restricted

Clinilabs Announces Medical Leadership Appointments5.8.2026 16:05:00 CEST | Press release

Bob Dagher, M.D., Named Chief Medical Officer and Waqar Ahmed Siddiqui, M.D., Named Principal Investigator Clinilabs (“Clinilabs LLC”), a global, full-service contract research organization (CRO) specializing in central nervous system (CNS) drug and device development, today announced the appointments of Bob Dagher, M.D., as Chief Medical Officer and Waqar Ahmed Siddiqui, M.D., as Principal Investigator of the Company’s Eatontown, New Jersey Clinical Research Unit (CRU). Dr. Dagher will provide strategic and medical leadership across the organization, while Dr. Siddiqui will lead the execution of research projects at the Company’s CRU. Together, they will support the design, development, and execution of clinical programs for pharmaceutical, biotechnology, and medical device sponsors advancing innovative therapies for psychiatric, neurological, substance use, and rare CNS disorders. “Clinilabs has earned the trust of sponsors by combining deep scientific expertise, medical leadership,

Interactive Brokers Adds Brazilian Futures through Brazil’s B3 Exchange5.8.2026 16:00:00 CEST | Press release

Interactive Brokers (Nasdaq: IBKR), an automated global broker, today announced that eligible clients outside of Brazil can now trade Brazilian futures in addition to equities through the B3 exchange. Interactive Brokers was the first broker to provide international investors with streamlined, low-cost access to B3. Offering Brazilian futures and equities alongside products across more than 170 markets worldwide underscores IBKR’s commitment to broadening global market access and giving clients efficient, cost-effective ways to diversify through a single, unified platform. Access to B3 provides exposure to one of Latin America’s most active and liquid markets, providing long-term growth potential across multiple sectors and another way for investors to pursue emerging market opportunities. "Global investors deserve seamless, low-cost access to the world's most compelling markets, including emerging economies shaping tomorrow's financial landscape," said Milan Galik, Chief Executive Off

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye